Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 139, 2019 - Issue 2
Submit an article Journal homepage
1,966
Views
7
CrossRef citations to date
0
Altmetric
Articles

TLR5 and TLR7 are differentially expressed in human papillomavirus-positive and negative base of tongue squamous cell carcinoma, and TLR7 may have an independent prognostic influence

Linnea HaeggblomDepartment of Oncology-Pathology, Karolinska Institute, CCK, Stockholm, Sweden; View further author information
,
Anders NäsmanDepartment of Clinical Pathology, Cancer Center Karolinska, Karolinska Institute, Stockholm,Sweden; View further author information
,
Torbjörn RamqvistDepartment of Oncology-Pathology, Karolinska Institute, CCK, Stockholm, Sweden; View further author information
,
Caj HaglundDepartment of Pathology, Haartman Institute and HusLab, Helsinki University Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; View further author information
,
Jaana HagströmDepartment of Pathology, Haartman Institute and HusLab, Helsinki University Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; View further author information
,
Antti MäkitieDepartment of Otorhinolaryngology – Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; ; Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, SwedenView further author information
&
Tina DalianisDepartment of Oncology-Pathology, Karolinska Institute, CCK, Stockholm, Sweden; Correspondence[email protected]
View further author information
 show all
Pages 206-210 | Received 05 Sep 2018, Accepted 18 Nov 2018, Published online: 22 Feb 2019

References

  • Mellin H, Friesland S, Lewensohn R. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000;89:300–304.
  • Attner P, Du J, Nasman A, et al. Human papillomavirus and survival in patients with base of tongue cancer. Int J Cancer. 2011;128:2892–2897.
  • Dalianis T. Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy. Int J Oncol. 2014;44:1799–1805.
  • Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer. 2007;110:1429–1435.
  • Nasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. Int J Cancer. 2009;125:362–366.
  • Attner P, Du J, Nasman A, et al. The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer. 2010;126:2879–2884.
  • Nasman A, Nordfors C, Holzhauser S, et al. Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma?. Eur J Cancer. 2015;51:55–61.
  • Mirghani H, Amen F, Blanchard P, et al. Treatment de-escalation in HPV − positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives. Int J Cancer. 2015;136:1494–1503.
  • Nasman A, Bersani C, Lindquist D, et al. Human papillomavirus and potentially relevant biomarkers in tonsillar and base of tongue squamous cell carcinoma. Anticancer Res. 2017;37:5319–5328.
  • Lindquist D, Ährlund-Richter A, Tarjan M, et al. Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer. Anticancer Res. 2012;32:153–161.
  • Nordfors C, Grun N, Tertipis N, et al. CD8+ and cD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. Eur J Cancer. 2013;49:2522–2530.
  • Tertipis N, Hammar U, Nasman A, et al. A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancer. Eur J Cancer. 2015;51:1580–1587.
  • Bersani C, Mints M, Tertipis N, et al. A model using concomitant markers for predicting outcome in human papillomavirus positive oropharyngeal cancer. Oral Oncol. 2017;68:53–59.
  • Bersani C, Sivars L, Haeggblom L, et al. Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated fgfr3. Oncotarget. 2017;8:35339–35350.
  • Jouhi L, Mohamed H, Mäkitie A, et al. Toll-like receptor 5 and 7 expression may impact prognosis of HPV − positive oropharygeal squamous cell carcinoma. Cancer Immunol Immunother. 2017;66:1619–1629.
  • Janeaway CAJR. Approaching the asymptote. Evolution and revolution in immunology. Cold Spring Harb Syp Quant Biol. 1989;54:1–13.
  • Kawai T, Akira S. Pathogen recognition with Toll-like receptors. Curr Opin Immunol. 2005;17:338–344.
  • Smeets SJ, Hesselink AT, Speel E-JM, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer. 2007;121:2465–2472.
  • Dalianis T, Grun N, Koch J, et al. Human papillomavirus DNA and p16(ink4a) expression in hypopharyngeal cancer and in relation to clinical outcome, in stockholm, sweden. Oral Oncol. 2015;51:857–861.
  • Jouhi L, Datta N, Renkonen S, et al. Expression of toll-like receptors in HPV − positive and HPV − negative oropharyngeal squamous cell carcinoma–an in vivo and in vitro study. Tumor Biol. 2015;36:7755–7764.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.